IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
34 hedge funds and large institutions have $3.35M invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$633K | |
| 2 | +$63.5K | |
| 3 | +$36.3K | |
| 4 |
Renaissance Technologies
New York
|
+$19.6K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$5.25K |
Top Sellers
| 1 | -$9.16K | |
| 2 | -$5.16K | |
| 3 | -$5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.56K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.79K |